SOHO 2022 Tenth Annual Meeting
Playback speed
10 seconds
SOHO 2022: AGILE - A Phase 3, Global, Randomized, Double-Blind Study of Ivo + Aza vs. Placebo + Aza in Newly Diagnosed AML With an IDH1 Mutation
19 views
October 14, 2022
Comments 0
Login to view comments.
Click here to Login